Sequence Issue #4: 163 lives saved….and countingPublished: May 4th 2018
Ten years ago, Newfoundland researchers cracked the genetic code of a cardiac disease that causes death in seemingly healthy young people. The disease, Type 5 ARVC, is particularly prevalent in Newfoundland and Labrador. Genome Atlantic recently caught up with researchers Drs. Terry-lynn Young and Kathy Hodgkinson to find out what’s happened since their genetic breakthrough – as it turns out, plenty. More than 500 people have been tested and 163 people fitted with life-saving defibrillators. Watch one patient’s story in the brief, compelling video:
We also checked in with Drs. Chris McMaster and Johane Robitaille on their continuing work in orphan disease discovery and therapies. Seven years ago, McMaster launched a research project called IGNITE to improve our understanding, diagnosis and treatment of orphan diseases. Multiple gene discoveries and therapies later, this remarkable research team continues to unlock the power of clinical genetics to improve the lives of people with orphan diseases.
Watch this brief video on how the Government of Canada’s recent announcement of $225 million for genomics and precision health research – including on orphan diseases – is bringing new hope for Canadian patients.
Genomics is a powerful tool for many sectors and is one of five pillars of the recently announced Atlantic Canada-based Ocean Supercluster. Genome Atlantic joined a recent Ocean Supercluster celebration in St. John’s, NL, hosted by Petroleum Research Newfoundland and Labrador. Perhaps Hon. Seamus O’Regan summed it up best when he said, “We came here for the ocean’s riches. We have the expertise that can take on the world. So let’s take it on.”
Oil-eating microbes? They’re real and they may just help unlock the secret of Nova Scotia’s offshore petroleum reserves. We’ve commissioned a video to tell the story, and while it won’t wrap up for a bit, here’s a sneak peek.
Genome Atlantic is helping to “create great things from life” in Atlantic Canada’s bioscience sectors. Find out how in this Opinion Piece published in The Telegram (St. John’s, NL) and Guardian (Charlottetown, PE).
The role of genomics is expanding quickly – not just in traditional sectors but in emerging fields like synthetic biology. Ontario Genomics recently hosted Canada’s first national conference on synthetic biology which combines biology and engineering to design and construct new biological entities – or as one of the speakers put it, “Synthetic biology means engineering biology to make useful stuff.” The conference covered a lot of ground, from developing new therapeutics to reducing our climate footprint – all “useful stuff” indeed!